| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |